Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Disease, Chronic Obstructive | 20 | 2024 | 3047 | 2.300 |
Why?
|
| Cystic Fibrosis | 4 | 2022 | 1177 | 1.210 |
Why?
|
| Genomic Imprinting | 4 | 2014 | 328 | 1.110 |
Why?
|
| Bronchitis, Chronic | 1 | 2022 | 62 | 0.830 |
Why?
|
| Glycoproteins | 2 | 2020 | 2263 | 0.700 |
Why?
|
| Phosphoproteins | 2 | 2020 | 2440 | 0.660 |
Why?
|
| F-Box Proteins | 1 | 2019 | 197 | 0.610 |
Why?
|
| Autoantigens | 2 | 2020 | 892 | 0.520 |
Why?
|
| Alternative Splicing | 2 | 2023 | 1117 | 0.510 |
Why?
|
| Asthma | 3 | 2023 | 6011 | 0.500 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2014 | 107 | 0.460 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 3 | 2023 | 451 | 0.450 |
Why?
|
| Pulmonary Emphysema | 3 | 2024 | 672 | 0.450 |
Why?
|
| Spermatogenesis | 1 | 2012 | 262 | 0.390 |
Why?
|
| Emphysema | 2 | 2024 | 247 | 0.370 |
Why?
|
| Genome-Wide Association Study | 5 | 2023 | 12261 | 0.350 |
Why?
|
| Telomere | 1 | 2014 | 910 | 0.310 |
Why?
|
| Pneumonia | 1 | 2020 | 2133 | 0.310 |
Why?
|
| Forced Expiratory Volume | 5 | 2023 | 1743 | 0.300 |
Why?
|
| Fatty Acid-Binding Proteins | 2 | 2020 | 300 | 0.270 |
Why?
|
| Toll-Like Receptors | 2 | 2021 | 592 | 0.270 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2020 | 15519 | 0.260 |
Why?
|
| Heterozygote | 3 | 2022 | 2804 | 0.250 |
Why?
|
| Exons | 3 | 2023 | 2437 | 0.250 |
Why?
|
| Translocation, Genetic | 1 | 2010 | 1420 | 0.250 |
Why?
|
| Sequence Analysis, RNA | 4 | 2022 | 2012 | 0.240 |
Why?
|
| Lung | 5 | 2023 | 9856 | 0.220 |
Why?
|
| RNA Splice Sites | 1 | 2023 | 209 | 0.210 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 1678 | 0.210 |
Why?
|
| Lymphocytes | 1 | 2010 | 2617 | 0.200 |
Why?
|
| Janus Kinase 1 | 2 | 2022 | 104 | 0.200 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2022 | 164 | 0.200 |
Why?
|
| Proteins | 1 | 2015 | 6103 | 0.180 |
Why?
|
| Arylsulfotransferase | 1 | 2019 | 28 | 0.180 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2022 | 337 | 0.180 |
Why?
|
| Quantitative Trait Loci | 2 | 2019 | 2019 | 0.170 |
Why?
|
| Metal Nanoparticles | 2 | 2021 | 405 | 0.170 |
Why?
|
| DNA Methylation | 2 | 2012 | 4286 | 0.170 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2022 | 437 | 0.170 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2019 | 82 | 0.170 |
Why?
|
| Respiration Disorders | 1 | 2022 | 371 | 0.170 |
Why?
|
| Nanomedicine | 1 | 2021 | 304 | 0.160 |
Why?
|
| RNA Splicing | 1 | 2023 | 907 | 0.160 |
Why?
|
| Eosinophilia | 1 | 2022 | 541 | 0.160 |
Why?
|
| Gene Expression | 4 | 2021 | 7799 | 0.160 |
Why?
|
| Acute Lung Injury | 1 | 2021 | 380 | 0.150 |
Why?
|
| Nuclear Proteins | 1 | 2012 | 5853 | 0.150 |
Why?
|
| Proton Pump Inhibitors | 1 | 2021 | 526 | 0.140 |
Why?
|
| Epigenesis, Genetic | 1 | 2010 | 3647 | 0.140 |
Why?
|
| Phenotype | 6 | 2022 | 16365 | 0.140 |
Why?
|
| Respiratory Mucosa | 1 | 2020 | 427 | 0.140 |
Why?
|
| Hypereosinophilic Syndrome | 1 | 2017 | 93 | 0.140 |
Why?
|
| Genotype | 5 | 2023 | 12951 | 0.140 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2019 | 707 | 0.140 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2019 | 671 | 0.130 |
Why?
|
| Nanocapsules | 1 | 2016 | 91 | 0.130 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2019 | 1155 | 0.130 |
Why?
|
| Gene Expression Profiling | 5 | 2024 | 9438 | 0.130 |
Why?
|
| Cell Line | 4 | 2020 | 15997 | 0.120 |
Why?
|
| Immune System Diseases | 1 | 2017 | 262 | 0.120 |
Why?
|
| Gene Regulatory Networks | 1 | 2023 | 1708 | 0.120 |
Why?
|
| Genes, Dominant | 1 | 2017 | 880 | 0.120 |
Why?
|
| RNA, Untranslated | 1 | 2017 | 453 | 0.120 |
Why?
|
| Interleukin-8 | 1 | 2017 | 690 | 0.120 |
Why?
|
| Hypersensitivity | 1 | 2022 | 1102 | 0.120 |
Why?
|
| Endosomes | 1 | 2016 | 520 | 0.120 |
Why?
|
| Eosinophils | 1 | 2018 | 955 | 0.110 |
Why?
|
| Humans | 32 | 2024 | 744343 | 0.110 |
Why?
|
| Disease Progression | 4 | 2023 | 13284 | 0.110 |
Why?
|
| NF-kappa B | 1 | 2021 | 2499 | 0.110 |
Why?
|
| Iodide Peroxidase | 1 | 2014 | 293 | 0.110 |
Why?
|
| Mucin-5B | 2 | 2023 | 141 | 0.110 |
Why?
|
| STAT3 Transcription Factor | 1 | 2017 | 873 | 0.110 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2021 | 1861 | 0.100 |
Why?
|
| Saliva | 1 | 2015 | 809 | 0.100 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2022 | 1736 | 0.100 |
Why?
|
| Case-Control Studies | 4 | 2022 | 21746 | 0.100 |
Why?
|
| Fibroblasts | 1 | 2021 | 4161 | 0.100 |
Why?
|
| Phagocytosis | 1 | 2016 | 1539 | 0.090 |
Why?
|
| Spermatocytes | 1 | 2010 | 42 | 0.090 |
Why?
|
| Nitric Oxide Synthase | 1 | 2013 | 916 | 0.090 |
Why?
|
| Chromosome Pairing | 1 | 2010 | 47 | 0.090 |
Why?
|
| Alleles | 3 | 2017 | 6933 | 0.090 |
Why?
|
| Male | 16 | 2022 | 350118 | 0.090 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 4479 | 0.090 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2016 | 1836 | 0.090 |
Why?
|
| RNA, Messenger | 4 | 2023 | 13033 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2010 | 299 | 0.080 |
Why?
|
| Organ Specificity | 1 | 2014 | 2008 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2023 | 17446 | 0.080 |
Why?
|
| Female | 17 | 2022 | 380194 | 0.080 |
Why?
|
| Respiratory Function Tests | 2 | 2023 | 1616 | 0.080 |
Why?
|
| Spermatozoa | 1 | 2012 | 625 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 4 | 2021 | 21827 | 0.080 |
Why?
|
| Meiosis | 1 | 2010 | 339 | 0.080 |
Why?
|
| Mutation | 1 | 2012 | 29786 | 0.080 |
Why?
|
| Homozygote | 1 | 2012 | 1785 | 0.080 |
Why?
|
| Gene Expression Regulation | 3 | 2022 | 12072 | 0.080 |
Why?
|
| Oxygen | 1 | 2018 | 4189 | 0.070 |
Why?
|
| Aged, 80 and over | 5 | 2022 | 57776 | 0.070 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2019 | 1813 | 0.070 |
Why?
|
| Middle Aged | 11 | 2022 | 213383 | 0.070 |
Why?
|
| Transcription Factors | 2 | 2022 | 12208 | 0.060 |
Why?
|
| Epithelial Cells | 1 | 2017 | 3690 | 0.060 |
Why?
|
| Gene Deletion | 1 | 2012 | 2751 | 0.060 |
Why?
|
| Peptides | 1 | 2016 | 4409 | 0.060 |
Why?
|
| Aged | 9 | 2022 | 163280 | 0.060 |
Why?
|
| Immunity, Innate | 1 | 2015 | 2958 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2010 | 1538 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2022 | 15540 | 0.050 |
Why?
|
| Adult | 8 | 2023 | 214055 | 0.050 |
Why?
|
| Genes, Overlapping | 1 | 2021 | 36 | 0.050 |
Why?
|
| Penetrance | 1 | 2023 | 381 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2010 | 6386 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2010 | 2969 | 0.050 |
Why?
|
| Vital Capacity | 1 | 2023 | 925 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2022 | 23338 | 0.050 |
Why?
|
| Proteomics | 2 | 2024 | 3638 | 0.040 |
Why?
|
| Mice | 4 | 2021 | 81183 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2010 | 3023 | 0.040 |
Why?
|
| Interferons | 1 | 2022 | 706 | 0.040 |
Why?
|
| DNA | 1 | 2012 | 7301 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 9734 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2021 | 23403 | 0.040 |
Why?
|
| Chemokine CXCL1 | 1 | 2017 | 101 | 0.040 |
Why?
|
| Nanoconjugates | 1 | 2016 | 22 | 0.040 |
Why?
|
| Animals | 5 | 2022 | 168757 | 0.040 |
Why?
|
| E-Selectin | 1 | 2019 | 579 | 0.040 |
Why?
|
| Child | 3 | 2023 | 77709 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2022 | 2634 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2022 | 2715 | 0.030 |
Why?
|
| Adolescent | 2 | 2015 | 85781 | 0.030 |
Why?
|
| Multifactorial Inheritance | 1 | 2022 | 1194 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2010 | 6544 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2018 | 1588 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2022 | 13989 | 0.030 |
Why?
|
| Prospective Studies | 3 | 2023 | 53288 | 0.030 |
Why?
|
| Blood Proteins | 1 | 2019 | 1124 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2013 | 170 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2017 | 541 | 0.030 |
Why?
|
| Gold | 1 | 2016 | 484 | 0.030 |
Why?
|
| Inflammation | 2 | 2022 | 10638 | 0.030 |
Why?
|
| Polysomnography | 1 | 2019 | 1776 | 0.030 |
Why?
|
| Thyroid Hormones | 1 | 2014 | 390 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2013 | 534 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2016 | 2557 | 0.030 |
Why?
|
| Methylation | 1 | 2014 | 1106 | 0.030 |
Why?
|
| Zebrafish | 1 | 2022 | 2994 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2013 | 689 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2022 | 9849 | 0.020 |
Why?
|
| Pedigree | 1 | 2017 | 4644 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2019 | 6459 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2017 | 1788 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2022 | 10252 | 0.020 |
Why?
|
| Brain | 1 | 2014 | 26385 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 2703 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2016 | 1790 | 0.020 |
Why?
|
| Cytokines | 1 | 2021 | 7322 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2022 | 15076 | 0.020 |
Why?
|
| Risk Factors | 2 | 2023 | 72290 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 12245 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2019 | 9146 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 5867 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 18029 | 0.010 |
Why?
|
| Genomics | 1 | 2018 | 5720 | 0.010 |
Why?
|
| Prognosis | 1 | 2023 | 29063 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2016 | 19229 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 20129 | 0.010 |
Why?
|
Concepts
(168)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(28)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_